Open AccessReal-World Effectiveness and Safety of Apixaban versus Warfarin in Patients with Acute Venous Thromboembolism: Experience of a Large Tertiary Hospital in Saudi Arabia
Author(s) -
Majed S. Al Yami,
Mohammed Alzahrani,
Abdulmajeed Alshehri,
Omar A. Alshaya,
Norah S Alsubiae,
Yazeed Jazaa Alharbi,
Latifah K Albaiahy,
Mounira Aldeiban,
Haya A Alkuait,
Wejdan Alobaidi,
Anas S. Aldawsari,
Nouf Mohammed Almutairi,
Mohannad Alshibani,
Ghazwa B. Korayem,
Osamah M. Alfayez,
Abdulaali R. Almutairi,
Omar A. Almohammed
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s322221
Subject(s) - medicine , apixaban , warfarin , odds ratio , incidence (geometry) , retrospective cohort study , pulmonary embolism , deep vein , cohort , thrombosis , surgery , atrial fibrillation , rivaroxaban , optics , physics
The main objective of this study was to evaluate the effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism (VTE) in a "real-world" setting.